• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hemorheology in surgery--a review.

作者信息

Müller R, Musikić P

出版信息

Angiology. 1987 Aug;38(8):581-92. doi: 10.1177/000331978703800802.

DOI:10.1177/000331978703800802
PMID:3307545
Abstract

The rheological behavior of blood and its components under physiologic and pathophysiologic conditions is reviewed, with a focus on the type and extent of pathohemorheological changes in surgical patients during hospitalization and thereafter, as well as their clinical consequences with regard to thromboembolic complications. During the operation and the postoperative period various hemorheological and hemostasiological alterations acquire clinical significance: 1. hyperreagibility of platelets with increased aggregation and adhesion tendency 2. changes in fibrinogen, albumin, and globulin concentrations, which affect viscosity and red cell aggregation 3. impairment of red cell deformability 4. increase in clotting factors 5. disturbance of fibrinolysis characterized by diminution of plasmatic plasmin and increase in antiplasmin activity In addition, anesthetic techniques have also been shown to affect hemorheological and hemostasiological parameters. The complex pattern of pathohemorheological and hemostasiological changes shows that thromboembolism in the course of surgical interventions is provoked by multifactorial disorders. Thrombosis prevention should, therefore, counteract both hemorheological and hemostasiological disturbances. Since pathohemorheological and pathohemostasiological changes are already detectable before, and increase during operation, preventive measures should start before the surgical intervention to obtain maximum benefit. Therapeutic possibilities for the avoidance of these multifactorial disturbances are discussed with particular reference to pentoxifylline, which satisfies the complex requirements of a hemorheologically and hemostasiologically active therapeutic agent.

摘要

相似文献

1
Hemorheology in surgery--a review.
Angiology. 1987 Aug;38(8):581-92. doi: 10.1177/000331978703800802.
2
Hemorheology and peripheral vascular diseases: a new therapeutic approach.血液流变学与周围血管疾病:一种新的治疗方法。
J Med. 1981;12(4):209-35.
3
A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.己酮可可碱(曲克芦丁400)治疗间歇性跛行的对照试验:临床、止血和流变学效应
N Z Med J. 1987 Jul 22;100(828):445-7.
4
Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
Angiology. 1985 Jun;36(6):387-98. doi: 10.1177/000331978503600608.
5
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.己酮可可碱治疗周围阻塞性动脉疾病的临床药理学及疗效研究。
Angiology. 1984 Jul;35(7):427-35. doi: 10.1177/000331978403500705.
6
Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Angiology. 1984 Jul;35(7):459-66. doi: 10.1177/000331978403500709.
7
Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.己酮可可碱或西洛他唑未能改善间歇性跛行患者的血液和血浆粘度、纤维蛋白原及红细胞变形性。
Angiology. 2002 Sep-Oct;53(5):509-20. doi: 10.1177/000331970205300503.
8
Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
Semin Thromb Hemost. 1989 Apr;15(2):150-8. doi: 10.1055/s-2007-1002698.
9
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Circulation. 1985 Nov;72(5):1059-63. doi: 10.1161/01.cir.72.5.1059.
10
Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.己酮可可碱对脑血管疾病患者进行血液流变学活性治疗的结果。
Angiology. 1989 Nov;40(11):987-93. doi: 10.1177/000331978904001109.

引用本文的文献

1
Epidemiology of Canine and Its Hemorheology Characteristics.犬类流行病学及其血液流变学特征。
Animals (Basel). 2024 Sep 12;14(18):2658. doi: 10.3390/ani14182658.
2
Biochemical implications of robotic surgery: a new frontier in the operating room.机器人手术的生化意义:手术室的新前沿。
J Robot Surg. 2024 Feb 24;18(1):91. doi: 10.1007/s11701-024-01861-6.
3
Effects of Age and Season on Blood Parameters of Captive Giant Pandas: A Pilot Study.年龄和季节对圈养大熊猫血液参数的影响:一项初步研究。
Animals (Basel). 2023 Sep 26;13(19):3023. doi: 10.3390/ani13193023.
4
COVID-19 Vaccination and Bariatric Surgery.2019冠状病毒病疫苗接种与减肥手术
Obes Surg. 2022 Apr;32(4):1358. doi: 10.1007/s11695-021-05840-w. Epub 2022 Jan 22.
5
Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury.右美托咪定可防止实验性肝缺血再灌注损伤中的脂质过氧化和红细胞变形能力改变。
Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.18185. Epub 2012 May 24.
6
A selective thromboxane synthetase inhibitor, OKY-046, fails to improve blood rheology in endotoxin-shocked rabbits.一种选择性血栓素合成酶抑制剂OKY - 046未能改善内毒素休克兔的血液流变学。
J Anesth. 1991 Jul;5(3):247-54. doi: 10.1007/s0054010050247.
7
The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.
J Gen Intern Med. 1993 Apr;8(4):213-9. doi: 10.1007/BF02599270.
8
The clinical importance of erythrocyte deformability, a hemorrheological parameter.红细胞变形性这一血液流变学参数的临床重要性。
Ann Hematol. 1992 Mar;64(3):113-22. doi: 10.1007/BF01697397.